VERU
Veru Inc.
There isn't enough reported data to score VERU yet.
VERU Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
VERU's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
VERU PE Valuation
VERU has no meaningful PE right now: it lost money over the past year.
VERU Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| -- | |
| -- | |
| Limited | |
| Low |
Analysts expect VERU's losses to shrink, with revenue holding steady. However, they disagree widely on these estimates.
VERU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.58 | +$1.65 |
| Q1 2026 | -$0.78 | +$1.65 |
| Q4 2025 | -$1.16 | +$1.47 |
| Q3 2025 | -$1.50 | +$1.33 |
| Q2 2025 | -$2.23 | +$0.57 |
| Q1 2025 | -$2.43 | +$0.47 |
| Q4 2024 | -$2.63 | +$4.37 |
| Q3 2024 | -$2.83 | +$7.97 |
VERU is still losing money, but far less than before: $0.58 per share over the past year, against $17.30 at its worst in early 2023.
VERU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2024 | $6.7M | +72% |
| Q2 2024 | $4M | +18% |
| Q1 2024 | $4.1M | -37% |
| Q4 2023 | $2.1M | -15% |
| Q3 2023 | $3.9M | +49% |
| Q2 2023 | $3.3M | -65% |
| Q1 2023 | $6.6M | -49% |
| Q4 2022 | $2.5M | -82% |
VERU's revenue has slid since its 2021 peak: $0 last quarter, down 100% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2024 | -123% | +88 points |
| Q2 2024 | -277% | -41 points |
| Q1 2024 | -239% | +359 points |
| Q4 2023 | -368% | +1051 points |
| Q3 2023 | -212% | +1514 points |
| Q2 2023 | -236% | -8.4 points |
| Q1 2023 | -599% | -508 points |
| Q4 2022 | -1419% | -1384 points |
VERU's operating margin was −123% last quarter, up 88 points from the same quarter a year ago.
VERU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$5.5M | +$15.1K |
| Q1 2026 | -$8.9M | -$1.2M |
| Q4 2025 | -$6.2M | +$5.2M |
| Q3 2025 | -$5.5M | -$1.1M |
| Q2 2025 | -$5.5M | +$218.1K |
| Q3 2024 | -$4.4M | +$5.3M |
| Q2 2024 | -$5.7M | +$12.8M |
| Q3 2023 | -$9.7M | +$11.3M |
VERU has burned cash in almost every quarter: −$26M over the past year, against −$29M the year before.
VERU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +57% | +8.4M shares |
| 3 years | +161% | +14.2M shares |
| 5 years | +189% | +15.1M shares |
| Available history | +264% | +16.7M shares |
VERU has 23M diluted shares, up 57% from a year ago.
VERU Net Leverage
VERU's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
VERU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.7 | Neutral |
| Stochastic | 9.7 | Oversold |
VERU's weekly RSI is 39 (neutral) and its Stochastic is 10 (oversold).
VERU PE vs Healthcare Sector
VERU has no meaningful PE right now: it lost money over the past year.
VERU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.31 | 8.2% below |
| 20 week MA | $2.45 | 13% below |
| 50 week MA | $2.47 | 14% below |
| 100 week MA | $3.78 | 44% below |
| 200 week MA | $7.98 | 73% below |
VERU is in a downtrend: it's below all five of its weekly moving averages, and 73% below its 200-week average.
VERU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.3 | $86.7 | +186% |
| 2021 | $86.7 | $62.9 | -27% |
| 2022 | $62.9 | $50.5 | -20% |
| 2023 | $50.5 | $7.20 | -86% |
| 2024 | $7.20 | $6.76 | -6.1% |
| 2025 | $6.76 | $2.40 | -64% |
| 2026 YTD | $2.40 | $2.12 | -12% |
VERU has finished five years in a row lower, and it's down 12% so far in 2026.